Crossmark

PD-1/PD-L1 inhibitors plus chemotherapy versus chemotherapy alone as the first line treatment for advanced biliary tract cancer: a pooled analysis of KEYNOTE-966 and TOPAZ-1 trails

Crossref DOI link: https://doi.org/10.1186/s12957-025-03877-0

Published Online: 2025-06-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Jiashou

Xu, Yun

Hong, Bo

Hou, Qingjian

Chen, Wenying

Zhang, Wenxiong

Zheng, Wen
Funding

Funding for this research was provided by:

Science and Technology Plan Project of Jiangxi Provincial Health Commission (202410952)
License Information

Text and Data Mining valid from 2025-06-10

Version of Record valid from 2025-06-10
More Information

Article History

Received: 24 December 2024

Accepted: 1 June 2025

First Online: 10 June 2025

Declarations

:

: Due to the nature of this study no ethical approval was required.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below